IP Library Granted Patent US 8,318,463
Granted Patent B2
US 8,318,463 · App. 12/825,537 · Granted Nov 27, 2012

Δ8 desaturases and their use in making polyunsaturated fatty acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,318,463
App. No.
12/825,537
Granted
Nov 27, 2012
Kind
B2
Abstract

The present invention relates to Δ8 desaturase genes, which have the ability to convert eicosadienoic acid (EDA; 20:2 ω-6) to dihomo-γ-linolenic acid (DGLA; 20:3 ω-6) and/or eicosatrienoic acid (ETrA; 20:3 ω-3) to eicosatetraenoic acid (ETA; (20:3 ω-3). Isolated nucleic acid fragments and recombinant DNA constructs comprising such fragments encoding Δ8 desaturases along with a method of making long-chain polyunsaturated fatty acids (PUFAs) using these Δ8 desaturases in oleaginous yeast are disclosed.

Claims (16)

1. A method for the production of at least one polyunsaturated fatty acid comprising:

a) providing an isolated microbial host cell comprising:

i) a recombinant nucleotide molecule encoding a polypeptide having delta-8 desaturase activity, wherein the polypeptide has at least 90% amino acid identity, based on the Clustal V method of alignment, when compared to amino acid sequence selected from the group consisting of: SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23 and SEQ ID NO:24; and

ii) a source of a substrate polyunsaturated fatty acid selected from the group consisting of eicosadienoic acid and eicosatrienoic acid;

b) growing the isolated microbial host cell of step (a) under conditions wherein eicosadienoic acid is converted to dihomo-qamma-linolenic acid and eicosatrienoic acid is converted to eicosatetraenoic acid; and

c) optionally recovering the dihomo-gamma-linolenic acid or eicosatetraenoic acid or both of step (b).

2. The method of claim 1 , wherein the isolated microbial host cell is a Yarrowia , said polypeptide has the full-length amino acid sequence set forth in SEQ ID NO:40, and the recombinant nucleotide molecule comprises at least 208 codons which are optimized for expression in Yarrowia.

3. The method according to claim 1 , wherein:

a) the recombinant nucleotide molecule has the full-length nucleic acid sequence selected from the group consisting of SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20 and SEQ ID NO:39; and

b) the host cell is Yarrowia lipolytica.

4. The method according to claim 1 wherein the isolated microbial host cell is selected from the group consisting of yeast, algae, bacteria, euglenoids, stramenopiles and fungi.

5. The method according to claim 4 wherein the isolated microbial host cell is a fungus of the genus Mortierella.

6. The method according to claim 4 wherein the isolated microbial host cell is a stramenopile selected from the group consisting of: Thraustochytrium and Schizochytrium.

7. The method according to claim 4 wherein the isolated microbial host cell is an oleaginous yeast.

8. The method according to claim 7 wherein the isolated microbial host cell is an oleaginous yeast selected from the group consisting of: Yarrowia, Candida, Rhodotorula, Rhodosporidium, Cryptococcus, Trichosporon and Lipomyces.

9. The method of claim 1 , wherein the isolated microbial host further comprises a recombinant nucleotide molecule encoding a polypeptide having delta-9 elongase activity.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE DESIGNATION OF ASSIGNEE AS A DELAWARE CORPORATION TO A DELAWARE LIMITED LIABILITY COMPANY PREVIOUSLY RECORDED ON REEL 049880 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 28, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 051502/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT US HOLDING, LLC
Reel/Frame 049880/0001 →